2,064 Shares in iShares NASDAQ Biotechnology Index (IBB) Acquired by Glacier Peak Capital LLC

Glacier Peak Capital LLC purchased a new position in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,064 shares of the financial services provider’s stock, valued at approximately $220,000.

A number of other large investors have also modified their holdings of IBB. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,907,625 shares of the financial services provider’s stock worth $203,677,000 after purchasing an additional 1,271,750 shares during the last quarter. Natixis increased its stake in shares of iShares NASDAQ Biotechnology Index by 631.5% during the 1st quarter. Natixis now owns 1,150,000 shares of the financial services provider’s stock worth $122,751,000 after purchasing an additional 992,783 shares during the last quarter. Commerce Bank increased its stake in shares of iShares NASDAQ Biotechnology Index by 217.0% during the 4th quarter. Commerce Bank now owns 793,250 shares of the financial services provider’s stock worth $84,695,000 after purchasing an additional 543,005 shares during the last quarter. Meitav Dash Investments Ltd. acquired a new position in shares of iShares NASDAQ Biotechnology Index during the 4th quarter worth about $54,468,000. Finally, Alliancebernstein L.P. increased its stake in shares of iShares NASDAQ Biotechnology Index by 79.6% during the 4th quarter. Alliancebernstein L.P. now owns 1,140,301 shares of the financial services provider’s stock worth $121,750,000 after purchasing an additional 505,243 shares during the last quarter. 60.10% of the stock is currently owned by hedge funds and other institutional investors.

Shares of iShares NASDAQ Biotechnology Index stock traded up $0.12 during trading on Thursday, hitting $110.61. 13,925 shares of the stock were exchanged, compared to its average volume of 2,821,399. iShares NASDAQ Biotechnology Index has a 1-year low of $96.84 and a 1-year high of $119.30.

About iShares NASDAQ Biotechnology Index

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply